icon-folder.gif   Conference Reports for NATAP  
 
  EASL - The International Liver Congress 2014
49th Annual Meeting of the European
Association for the Study of the Liver
London, United Kingdom  April 9-13
Back grey_arrow_rt.gif
 
 
 
Sofosbuvir Compassionate Use Program for Patients with Severe Recurrent Hepatitis C Including Fibrosing Cholestatic Hepatitis Following Liver Transplantation
 
 
  Reported by Jules Levin
EASL 2014 April 9-13 London, UK
 
Xavier Forns1, Martin Prieto2, Michael Charlton3, John G. McHutchison4, William T. Symonds4, Diana Brainard4, Jill Denning4, Theo Brandt-Sarif4, Paul Chang4, Valerie Kivett4, Robert J. Fontana5, Thomas F. Baumert6, Audrey Coilly7, Lluis Castells8, François Habersetzer6
 
1Liver Unit, IDIBAPS, CIBEREHD, Hospital Clinic, Barcelona, Spain; 2Hepatology Unit, CIBEREHD, Hospital Universitari i Politecnic La Fe, Valencia, Spain; 3Mayo Clinic, Rochester, MN, USA; 4Gilead Sciences, Foster City, CA, USA; 5University of Michigan, Ann Arbor, MI, USA; 6Hopitaux Universitaires de Strasbourg, Inserm U 1110, Strasbourg, France; 7Centre Hepato-Bilaire, Hopital
Paul Brousse, Inserm UMR-S785, Villejuif, France; 8Liver Unit-Internal Medicine Department, CIBEREHD, Hospital Universitari Vall Hebron, Barcelona

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif